Previous Article | Next Article ![]()
Molecular and Cellular Biology, February 1999, p. 1427-1437, Vol. 19, No. 2
Howard Hughes Medical Institute and
Department of Pharmacology1 and
Department of Biochemistry,2
University of Washington School of Medicine, Seattle, Washington
Received 23 April 1998/Returned for modification 28 May
1998/Accepted 23 October 1998
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Regulation of Ribosomal S6 Protein
Kinase-p90rsk, Glycogen Synthase Kinase 3, and
-Catenin in Early Xenopus Development

-Catenin is a multifunctional protein that binds cadherins at
the plasma membrane, HMG box transcription factors in the nucleus, and
several cytoplasmic proteins that are involved in regulating its
stability. In developing embryos and in some human cancers, the
accumulation of
-catenin in the cytoplasm and subsequently the
nuclei of cells may be regulated by the Wnt-1 signaling cascade and by
glycogen synthase kinase 3 (GSK-3). This has increased interest in
regulators of both GSK-3 and
-catenin. Searching for kinase
activities able to phosphorylate the conserved, inhibitory-regulatory GSK-3 residue serine 9, we found p90rsk to be a
potential upstream regulator of GSK-3. Overexpression of
p90rsk in Xenopus embryos leads to
increased steady-state levels of total
-catenin but not of the free
soluble protein. Instead, p90rsk overexpression
increases the levels of
-catenin in a cell fraction containing
membrane-associated cadherins. Consistent with the lack of elevation of
free
-catenin levels, ectopic p90rsk was
unable to rescue dorsal cell fate in embryos ventralized by UV
irradiation. We show that p90rsk is a
downstream target of fibroblast growth factor (FGF) signaling during
early Xenopus development, since ectopic FGF signaling activates both endogenous and overexpressed
p90rsk. Moreover, overexpression of a dominant
negative FGF receptor, which blocks endogenous FGF signaling, leads to
decreased p90rsk kinase activity. Finally, we
report that FGF inhibits endogenous GSK-3 activity in
Xenopus embryos. We hypothesize that FGF and p90rsk play heretofore unsuspected roles in
modulating GSK-3 and
-catenin.
*
Corresponding author. Mailing address: Howard Hughes
Medical Institute, Campus Box 357370, University of Washington School of Medicine, Seattle, WA 98195. Phone: (206) 543-1722. Fax: (206) 616-4230. E-mail: rtmoon{at}u.washington.edu.
Present address: Department of Molecular and Cellular Physiology,
Beckman Center for Molecular and Genetic Medicine, Stanford University
School of Medicine, Stanford, CA 94305-5426.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|